TCL Archive Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990 January 27, 1989
TCL Archive The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power October 31, 2014
TCL Archive Medicare coverage and quality of care top ASCO’s list of policy priorities for 2004. February 27, 2004
